The platelet-derived endothelial cell growth factor (PD-ECGF) is one of the potent angio genic factors. Recently, its homology with thymidine phosphorylase (dThdPase), an enzyme involved in pyrimidine nucleoside metabolism, has been shown. In the present study, dThdPase activity was evaluated spectrophotometrically in 43 breast carcinomas and in 19 cases of non-neoplastic breast tissues. The mean dThdPase activity in breast cancer was al most six fold higher than in normal, non-neoplastic breast tissues (1.92 and 0.29 (.imol thymine (T) x mg prot. -1 x h respectively). The enzyme activity significantly correlated with axillary lymph node status {p = 0.0076) and with tumor size (p = 0.0099). Besides, the intratumoral microvessel density (MD) was evaluated using the CD 31 mouse anti-human monoclo nal antibody, and there was no correlation between the level of enzymatic activity and a number of microvessels. The positive significant correlation of thymidine phosphorylase ac tivity with prognostic factors in breast cancer patients with no relation to the number of microvessels needs further examination to confirm the prognostic significance of the level of dThdPase.
Introduction
Angiogenesis plays a crucial role in tumor pro gression and metastases formation in many of hu man malignancies. There is a lot of evidence that microvessels density is an independent prognostic factor in gastrointestinal tumors (Chung et al., 1996) , endometrial carcinoma (Kaku et al., 1997) and breast carcinoma . The starting point for the formation of the vasculature is endothelial cell differentiation, proliferation, and finally organisation into the blood islands, and vascular structures. These phenomena are regu lated by a paracrine system, which includes several angiogenic and anti-angiogenic peptides.
Platelet-derived endothelial cell growth factor (PD-ECGF) was described as a potent angiogenic factor present in platelets (Ishikawa et al., 1989) . PD-ECGF has chemotactic properties for endo thelial cells in vitro and angiogenic activity in vivo (Folkman, 1996 : Takayashi et al., 1996 . PD-ECGF expression correlated well with an intensity of an giogenesis in breast carcinoma (Relf et al., 1997) .
Recently, the homology between PD-ECGF and thymidine phosphorylase (dThdPase) has been de monstrated (Moghdam et al., 1995; .
Thymidine phosphorylase is an enzyme involved in pyrimidine nucleoside metabolism. Human dThdPase catalyses the reversible phosphorolysis of the thymidine and other pyrimidine-2'-deoxyribosides. Pauly demonstrated elevated levels of plasma concentration of dThdPase in breast can cer patients in comparison with healthy volunteers (Pauly et al., 1977) . Similarly, almost ten-fold over expression of dThdPase in human tumors com pared to normal tissues was shown (Moghdam et al., 1995; Toi et al., 1995) . Furthermore, it seems that overexpression of dThdPase correlates with microvessels density in breast carcinoma (Toi et al., 1995) and intensity of angiogenesis in colon carcinoma (Folkman, 1996; Takayashi et al., 1996; .
In this paper we studied a correlation between enzymatic activity of dThdPase and clinical data (lymph node status, tumor size, and carcinoma 0939-5075/99/1200-1096 $ 06.00 © 1999 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com • D grade), and with microvessels density in breast carcinoma.
Lymph node status, tumor size and histological grade are factors of the most important prognostic significance in breast carcinoma.
Material and Methods

Breast tissue
Breast cancer tissue was obtained from 43 pa tients undergoing mastectomy. Tissue samples (ap proximately 0.5 cm3) were dissected from tumors immediately following surgery and frozen in low temperature (-80 °C) until required. Besides, in 19 cases, normal breast tissues (non-tumoral) were obtained at the time of mastectomy. All these sam ples were histologically proven to be non-neoplas tic.
All patients (except one) underwent modified radical mastectomy with a full axillary lymph nodes dissection. One patient was subjected to a simple mastectomy. Every case was divided into classes depending on tumor size -< 2 cm. and > 2 cm. Besides, the number of involved lymph nodes was coded as class I -no metastases, class II -1-3 metastases and class III > 3 metastases.
Histology and immunohistochemistry.
For the routine purposes, hematoxilin and eosin staining were performed. Histological diagnoses were done according to the W H O criteria using Bloom-Richardson grading system for the Ductal Carcinoma NOS (not otherwise specified) (Bloom and Richardson, 1957) .
For the immunohistochemistry staining, rou tinely processed, formalin-fixed, paraffin embed ded, tissue blocks were cut on silanized slides. Microvessel assessment was performed using a mouse anti-human CD 31 (Dako) antibody in di lution 1:40 with streptavidin-biotin technique following prolonged (13 min) enzymatic digestion with trypsin. Microvessel counting, according to the Weidner method (Vermeulen et al., 1996) , was initiated in those areas of most intensive vasculari zation (hot-spots) identified by scanning the speci men at low power magnification. Counting was continued in ten consecutive high power fields (400X) and was performed independently by two pathologists [R. K.,D.J-K.]. In cases of more than 15% discrepancy, two pathologists repeated count ing simultaneously, and the consensus result was obtained. Any positive staining cell or cells cluster (with or without lumen) was included into a scor ing. As the scoring result, a median per one high power field was calculated.
Enzyme assay
Preparation of the cytosol fraction
Tissue samples were homogenised in a glass homogenizer in 4 vol. of ice cold buffer (1 m M EDTA, 0.02% mercaptoethanol, 2 mM phenylmethanesulfonyl fluoride [PMSF] , 10 m M tris (hydroxymethyl) aminomethane -maleate, pH 6, 5) with 10% glycerol and then centrifuged at 100000xg for 1 h, to obtain cytosol fraction. It was then pooled and directly taken for analysis.
Enzyme assay dThdPase activity was assessed by the spectrophotometric method described by Yoshimura (Yoshimura et al., 1990) in our own modification, using the formation of thymine (T) from thymi dine in the presence of arsenate. The incubation mixture of 0.5 ml final volume contained 0.1 m tris (hydroxymetyl) aminomethane -arsenate buffer (pH 6.5), 10 m M dThd and cytosol fraction. After a 1 -h incubation at 37 °C, the reaction was stopped by adding 0.5 ml 1m NaOH and the thy mine formed was measured with absorbance at 300 nm. The protein content was determined ac cording to the method described by Bradford (1976) .
One unit of activity of dThdPase was defined as the amount of the enzyme which was required to form 1 [ am of free base per 1 hr. Specific activity was defined as the number of the enzyme activity units per milligram of protein.
Statistical analysis
Statistical analysis was performed using Kruskal-Wallis ANOVA, the median test and Spearman range correlation to evaluate the signifi cance of the differences. The p < 0.05 was taken as the level of statistical significance.
Results
Activity of dThdPase
The activity of dThdPase measured as [.imol of T x mg prot. _1 x h _1 in normal tissues (19 cases) ranged from 0.10 to 0.64. The mean activity in 19 cases of the normal breast tissue was 0.29 [.imol of T x mg prot. _1 x h -1 (Table I ). The mean enzyme activity in non-neoplastic tissue (range from 0.80 to 4.38 [imol of T x mg prot. _1 x h _1) was signifi cantly lower (p < 0.00005) than the activity of dThdPase in breast cancer tissue, where the mean activity was 1.92 [.imol of T x mg prot.
x h _1. The positive, significant correlation (p < 0.0076) was observed when dThdPase activity and lymph node status were compared. When the lymph ID C -Infiltrating Ductal Carcinoma, ILC -Infiltrating Lobular Carcinoma. * -dThdPase activity measured in [.imol of thymine (T) x mg prot. _1 x h _1. ** -number of microvessels per 1 high power field (microscope magnification 400 x). *** -not examined. **** _ sjmpie mastectomy. nodes metastases were scored into 3 classes, the thymidine phosphorylase activity raised with the score of involved lymph nodes (Fig. 1) .
Similar results were obtained for the correlation of dThdPase activity and a tumor size. The associa tion between maximal diameter of the tumor and the enzyme activity was statistically significantp = 0.0089. When the tumors were stratified into two groups: less than 20 mm, and more than 20 mm, the results were also significant (p = 0.0099) (Fig. 2) .
We found no correlation between the dThdPase activity and histological grade of breast cancer. Most of our patients (36) had Infiltrating ductal carcinoma NOS (IDC). When only ID C cases were analyses in regards to the Bloom and Rich ardson histological grade, the activity of the en zyme was higher in a grade II in comparison with a grade I, but this correlation was not statistically significant -p = 0.3299 (Fig. 3) .
Microvessels density (MD)
Assessing the M D in the tumor, we found no significant correlation between M D and enzyme activity, tumor size and lymph nodes status.
Discussion
Since the time when Folkman suggested, that tu mor growth was dependent on angiogenesis, the study of assessing angiogenesis and its regulatory mechanism has been under intensive investigation.
Several angiogenic and anti-angiogenic factors are currently known, and platelet-derived endo thelial cell growth factor (PD-ECGF) is one of them. PD-ECGF stimulates the growth and chemotaxis of endothelial cells in vitro and possesses angiogenic activity in vivo (Ishikawa et al., 1989) . Thymidine phosphorylase, which shows partial se quence homology with PD-ECGF (Furukawa et al., 1992), is an enzyme involved in the pyrimidine nu cleotide metabolism (Moghdam et al., 1995) .
In most recent studies to investigate the expres sion of PD-ECGF/dThdPase in histological sec tions, immunohistochemical methods were applied (Takayashi et al., 1996; Moghdam et al., 1995; Toi et al., 1995; Maeda et al., 1997; Giatromanolaki et al., 1997) , but merely, a few authors assessed the activity of dThdPase using spectrophotometric methods (Kubota et al., 1997) . Both methods show upregulation of dThdPase expression/activity in cancer tissues in comparison with adjacent, non neoplastic tissues . Anal ogously, we also demonstrated nearly six-fold higher enzyme activity in the tumor tissue.
The fact, that the dThdPase could exert a stimu latory effect on endothelial cells, raised the possi bility, that dThdPase activity may be a novel prog nostic factor. However, no correlation between dThdPase activity and prognosis in non-small cell lung cancer (Giatromanolaki et al., 1997) or pri mary breast carcinoma (Toi et al., 1995; Fox et al., 1996) was detected. Furthermore, Fox studying lymph node-positive breast tumors also found no differences, in relapse-free and overall survival in respect to the dThdPase expression (Fox et al., 1997) . On the other hand. Takebayashi studying gastrointestinal and lung cancers, showed a higher enzyme activity in more advanced stages (Takeb ayashi et al., 1996) . Similar results were obtained in bladder cancer by Kubota (Kubota et al., 1997) . Thus, the issue is not settled.
In our study, an association between the level of dThdPase activity and clinical features such as axillary lymph node status and a tumor size was shown. These results may reflect prognostic signi ficance of dThdPase, both in node-negative and node-positive breast carcinomas, but it clearly needs further investigation. The level of the activ ity of dThdPase should be further correlated with relapse-free and overall survival.
The majority of papers pointed-out to the corre lation between the level of dThdPase activity and a number of intratumoral microvessels in breast cancer patients (Relf et al., 1997; Toi et al., 1995; Toi et al., 1996) . Only Fox failed to show such a correlation . An absence of such a correlation in our studies is probably due to the small number of cases. Fox suggested, that dThdPase is important for remodelling of vascula ture only in an early stage of tumor development, because the chemotactic, not mitogenic properties of dThdPase . Moreover, Gasparini and Harris, reviewing the clinical importance of angiogenesis in breast cancer, found that prog nostic significance of microvessels density was dis closed in early-stage breast carcinomas (Gasparini and Harris, 1995) . However, other investigation (Folkman, 1996; Toi et al., 1995) suggested, that the level of dThdPase activity is associated with the activity of various cytokines and growth factors like interleukin -1 (IL-1), tumor necrosis factor a (TNF-a), interferon y or basic fibroblast growth factor (ß-FGF). Perhaps, in more advances stages of cancer these factors may play a more im portant role in a stimulation of the level of dThdPase, which in turn does not influence micro vessels count. Furthermore, apart from tumor cells, the expres sion of the dThdPase is exhibited in a variety of tumor infiltrating cells including macrophages or lymphocytes . It is un clear, however, whether this stimulatory pathway is really involved in tumoral angiogenesis.
We also investigated the putative association be tween intratumoral M D and both, lymph node status and tumor size. However, we showed no such a correlation, there several lines of evidence point to the M D as a prognostic factor in breast carcinoma (Obermair et al., 1995; Bevilacqua et al., 1995) . In a study on 130 cases of infiltrating ductal carcinoma Aranda revealed no correlation with lymph node status (Aranda and Laforga, 1996) . Similarly, Ravazoula found no association be tween M D and a number of metastases to axillary lymph nodes (Ravazoula et al., 1996) . Costello studied exclusively the lymph-node-negative breast cancer patients, showed no association of M D with clinical outcome and prognostic features such as tumor grade, and size, estrogen receptor status and accumulation of p53 protein (Costello et al., 1995) .
These conflicting results between possible prog nostic significance of dThdPase and lack of its cor relation with M D maybe due to relatively high heterogeneity in M D assessment. An international consensus on the methodology and criteria of evaluation of angiogenesis was suggested (Vermeulen et al., 1996) but many problems have still appeared during a tumor sampling. DeJong warned against the heterogeneity in M D between different areas from the same section, between corresponding areas in different sections and be tween different blocks from the same tumor (De Jong et al., 1995) .
